CYTK Sale Disclosure
Malik Fady Ibraham · SEC Form 4 · Filed Aug 18, 2026
Sale
Calculated transaction value
$265.37K
Malik Fady Ibraham EVP Research & Development
CYTK
Cytokinetics Inc
CYTK
Transaction date
Aug 18, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$76.1
Aug 18, 2026
Close before public filing
$75.87
Aug 17, 2026
Return since public filing
-2.77%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,500 shares @ $75.82
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001061983-26-000088
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$292.67K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Aug 18, 2026 | $27.3K |
| Cytokinetics Inc CYTK Current | Sale | Aug 18, 2026 | $265.37K |
| Cytokinetics Inc CYTK | Exercise | Aug 18, 2026 | $0 |